... in liquid form. ... However, generic medications are allowed to have different ... : The FDA has approved first-time generic formulations for cyclobenzaprine
HCl 5-mg tablets (Flexeril), clopidogrel bisulfate 75-mg tablets (Plavix), and ... Todayâ€™s health care cost crisis is widely feared. In a shocki...
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
FRAZER, Pa. and PHILADELPHIA, Oct. 21 /PRNewswire-FirstCall/ --
Cephalon, Inc. (Nasdaq: CEPH ) and Eurand NV (Nasdaq: EURX ) today announced
receipt of a Paragraph IV Certification Notice Letter on October 20, 2008
regarding an Abbreviated New Drug Application (ANDA) submitted to the U.S.
Cephalon Announces Issuance of Patent for AMRIX
...e AMRIX as an extended-release
capsule containing the muscle relaxant cyclobenzaprine. The AMRIX
formulation allows, for the first time, a full day of cyclobenzaprine
single dose medication for the treatment of acute painful musculoskeletal
"The issuance of this patent supports our investment in A...
Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
...hloride extended-release capsules), a new once-daily extended-release
skeletal muscle relaxant, was superior to placebo. AMRIX had similar
efficacy to cyclobenzaprine
immediate-release (CIR) taken three times a day
in alleviating acute muscle spasm associated with lower back and neck pain.
In addition, less daytime ...
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
therapy for longer periods is seldom warranted. With convenient, once-daily dosing, AMRIX provides relief from muscle
spasm comparable to that with cyclobenzaprine
hydrochloride taken three
times daily. In Phase 3 clinical trials, once daily dosing of AMRIX at 15
mg and 30 mg resulted in somnolence rates of one a...